Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Baker

Showing results (1191-1200 of 1,213) with videos related to

Pageof 122
Sort By:
Biorxiv : the Preprint Server for Biology|June 12, 2025
<i>De novo</i> design of miniprotein agonists and antagonists targeting G protein-coupled receptorsEdin Muratspahić, David Feldman, David E Kim, et al.
JACC. Advances|January 6, 2025
Propensity Score Analysis of Possible Medication Effects on Outcomes in Patients With Systemic Right VentriclesAmrit Misra, Carla P Rodriguez-Monserrate, Kimberlee Gauvreau, et al.
Biorxiv : the Preprint Server for Biology|December 16, 2024
Potent antitumor activity of a designed interleukin-21 mimicJung-Ho Chun, Birkley S Lim, Suyasha Roy, et al.
Science Immunology|September 26, 2025
Design of a potent interleukin-21 mimic for cancer immunotherapyJung-Ho Chun, Birkley S Lim, Suyasha Roy, et al.
European Heart Journal|August 18, 2023
End-stage heart failure in congenitally corrected transposition of the great arteries: a multicentre studyAlexandra C van Dissel, Alexander R Opotowsky, Luke J Burchill, et al.
The Journal of Infectious Diseases|June 10, 2021
Report of the National Institutes of Health SARS-CoV-2 Antiviral Therapeutics SummitMatthew D Hall, James M Anderson, Annaliesa Anderson, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2021
Multivalent designed proteins protect against SARS-CoV-2 variants of concernAndrew C Hunt, James Brett Case, Young-Jun Park, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 23, 2017
Quantitative historical analysis uncovers a single dimension of complexity that structures global variation in human social organizationPeter Turchin, Thomas E Currie, Harvey Whitehouse, et al.
Science Translational Medicine|April 12, 2022
Multivalent designed proteins neutralize SARS-CoV-2 variants of concern and confer protection against infection in miceAndrew C Hunt, James Brett Case, Young-Jun Park, et al.
Nature Communications|August 28, 2023
Translocator protein is a marker of activated microglia in rodent models but not human neurodegenerative diseasesErik Nutma, Nurun Fancy, Maria Weinert, et al.
Pageof 122

Showing results (1191-1200 of 1,213) with videos related to

Sort By:
Pageof 122
Biorxiv : the Preprint Server for Biology|June 12, 2025
<i>De novo</i> design of miniprotein agonists and antagonists targeting G protein-coupled receptorsEdin Muratspahić, David Feldman, David E Kim, et al.
JACC. Advances|January 6, 2025
Propensity Score Analysis of Possible Medication Effects on Outcomes in Patients With Systemic Right VentriclesAmrit Misra, Carla P Rodriguez-Monserrate, Kimberlee Gauvreau, et al.
Biorxiv : the Preprint Server for Biology|December 16, 2024
Potent antitumor activity of a designed interleukin-21 mimicJung-Ho Chun, Birkley S Lim, Suyasha Roy, et al.
Science Immunology|September 26, 2025
Design of a potent interleukin-21 mimic for cancer immunotherapyJung-Ho Chun, Birkley S Lim, Suyasha Roy, et al.
European Heart Journal|August 18, 2023
End-stage heart failure in congenitally corrected transposition of the great arteries: a multicentre studyAlexandra C van Dissel, Alexander R Opotowsky, Luke J Burchill, et al.
The Journal of Infectious Diseases|June 10, 2021
Report of the National Institutes of Health SARS-CoV-2 Antiviral Therapeutics SummitMatthew D Hall, James M Anderson, Annaliesa Anderson, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2021
Multivalent designed proteins protect against SARS-CoV-2 variants of concernAndrew C Hunt, James Brett Case, Young-Jun Park, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 23, 2017
Quantitative historical analysis uncovers a single dimension of complexity that structures global variation in human social organizationPeter Turchin, Thomas E Currie, Harvey Whitehouse, et al.
Science Translational Medicine|April 12, 2022
Multivalent designed proteins neutralize SARS-CoV-2 variants of concern and confer protection against infection in miceAndrew C Hunt, James Brett Case, Young-Jun Park, et al.
Nature Communications|August 28, 2023
Translocator protein is a marker of activated microglia in rodent models but not human neurodegenerative diseasesErik Nutma, Nurun Fancy, Maria Weinert, et al.
Pageof 122